Strikingly, it has been demonstrated that in HCT116 colon, carcinoma and in ccRCC cell lines, TRIM8 silencing induced p53 inactivation and MDM2 stabilization impairing Cisplatin and Nutlin-3 effect. This evidence concerns the gene TRIM8 and nonpapillary renal cell carcinoma.